Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
about
PATIENT-DERIVED XENOGRAFTS AS A PRECLINICAL MODEL FOR BONE SARCOMAS.Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor ModelExploring the OncoGenomic Landscape of cancer
P2860
Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Tumor engraftment in patient-d ...... al features and poor survival.
@en
type
label
Tumor engraftment in patient-d ...... al features and poor survival.
@en
prefLabel
Tumor engraftment in patient-d ...... al features and poor survival.
@en
P2093
P2860
P1433
P1476
Tumor engraftment in patient-d ...... al features and poor survival.
@en
P2093
Andrew L Warshaw
Andrew S Liss
Carlos Fernández-Del Castillo
Cristina R Ferrone
David P Ryan
Ilaria Pergolini
Keith D Lillemoe
Kim C Honselmann
Mari Mino-Kenudson
Marina Kem
P2860
P304
P356
10.1371/JOURNAL.PONE.0182855
P407
P577
2017-08-30T00:00:00Z